CRINETICS PHARMACEUTICALS IN's ticker is CRNX and the CUSIP is 22663K107. A total of 86 filers reported holding CRINETICS PHARMACEUTICALS IN in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $13,719,151 | +117.1% | 461,303 | +31.5% | 0.00% | +100.0% |
| Q2 2023 | $6,320,299 | +13.9% | 350,738 | +1.5% | 0.00% | 0.0% |
| Q1 2023 | $5,549,806 | -11.6% | 345,567 | +0.7% | 0.00% | 0.0% |
| Q4 2022 | $6,277,907 | -4.9% | 343,055 | +2.0% | 0.00% | 0.0% |
| Q3 2022 | $6,603,000 | +6.7% | 336,190 | +1.4% | 0.00% | 0.0% |
| Q2 2022 | $6,186,000 | -5.5% | 331,671 | +11.3% | 0.00% | 0.0% |
| Q1 2022 | $6,544,000 | -20.5% | 298,125 | +2.9% | 0.00% | 0.0% |
| Q4 2021 | $8,232,000 | +75.1% | 289,735 | +29.8% | 0.00% | 0.0% |
| Q3 2021 | $4,700,000 | +27.2% | 223,247 | +13.9% | 0.00% | +100.0% |
| Q2 2021 | $3,694,000 | +60.3% | 195,921 | +30.0% | 0.00% | 0.0% |
| Q1 2021 | $2,304,000 | +8.3% | 150,752 | +0.0% | 0.00% | 0.0% |
| Q4 2020 | $2,127,000 | -7.6% | 150,723 | +2.6% | 0.00% | 0.0% |
| Q3 2020 | $2,302,000 | -2.7% | 146,871 | +8.8% | 0.00% | 0.0% |
| Q2 2020 | $2,365,000 | +204.8% | 134,974 | +156.0% | 0.00% | – |
| Q1 2020 | $776,000 | -41.6% | 52,722 | -0.4% | 0.00% | -100.0% |
| Q4 2019 | $1,329,000 | +73.0% | 52,947 | +3.8% | 0.00% | – |
| Q3 2019 | $768,000 | -33.4% | 51,003 | +10.5% | 0.00% | -100.0% |
| Q2 2019 | $1,154,000 | +26.0% | 46,146 | +14.7% | 0.00% | 0.0% |
| Q1 2019 | $916,000 | -9.8% | 40,217 | +18.7% | 0.00% | 0.0% |
| Q4 2018 | $1,016,000 | -1.7% | 33,874 | -6.1% | 0.00% | 0.0% |
| Q3 2018 | $1,034,000 | – | 36,066 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Versant Venture Management, LLC | 410,360 | $11,658,000 | 6.24% |
| 5AM Venture Management, LLC | 862,286 | $24,498,000 | 4.60% |
| Bain Capital Life Sciences Investors, LLC | 2,029,701 | $57,664,000 | 4.57% |
| Opaleye Management Inc. | 724,400 | $20,580,000 | 4.36% |
| Deep Track Capital, LP | 1,900,000 | $53,979,000 | 3.81% |
| BVF INC/IL | 3,003,879 | $85,340,000 | 3.10% |
| FRAZIER MANAGEMENT LLC | 1,384,293 | $39,328,000 | 3.03% |
| Altium Capital Management LP | 331,000 | $9,404,000 | 2.59% |
| Perceptive Advisors | 10,327,034 | $293,392,000 | 2.26% |
| MPM BioImpact LLC | 379,792 | $10,790,000 | 1.97% |